Department of Medicine, University of British Columbia, 2775 Laurel Street, 10th Floor, Vancouver, BC, V5Z 1M9, Canada.
Arthritis Research Canada, Richmond, BC, Canada.
Rheumatol Int. 2018 Nov;38(11):1985-1997. doi: 10.1007/s00296-018-4132-z. Epub 2018 Aug 17.
Pain management is a cornerstone of osteoarthritis (OA) management. The aim of this review is to obtain current, literature-based estimates of the effect of common pharmacologic treatments on pain reduction in OA.
A MEDLINE search (2006-2016) was conducted for randomized controlled trials studying acetaminophen, oral NSAIDs, topical NSAIDs, COX-2 inhibitors, and opioids in the treatment of OA pain. Drug effect on pain was estimated using relative change in pain, and expressed as percentage change. An overall effect for each drug category was obtained as a weighted average of study-specific effects, with weights based on each study's sample size.
Twenty-nine studies were included. The effect on pain was estimated in a total of 43 treatment arms (acetaminophen n = 6, oral NSAIDs n = 9, topical NSAIDs n = 8, COX-2 inhibitors n = 9, and opioids n = 11). Relative (%) changes in pain were found to be as follows: acetaminophen = 32.5, oral NSAIDs = 34.3, topical NSAIDs = 40.9, COX-2 inhibitors = 36.9, and opioids = 35.4.
The effects of 5 major drug categories in the treatment of OA pain were reviewed with data extracted from 29 studies published from 2006 to 2016. Acetaminophen was found to have an RC value close to that of oral NSAIDs. The effects of oral NSAIDs, COX-2 inhibitors, and opioids in controlling pain were similar to what has been demonstrated in previous literature. Topical NSAIDs were found to have a greater RC than oral NSAIDs.
疼痛管理是骨关节炎(OA)管理的基石。本综述的目的是获得当前基于文献的常用药物治疗对 OA 疼痛减轻效果的估计。
对 2006 年至 2016 年的 MEDLINE 进行了检索,以查找研究乙酰氨基酚、口服 NSAIDs、局部 NSAIDs、COX-2 抑制剂和阿片类药物治疗 OA 疼痛的随机对照试验。使用疼痛相对变化来估计药物对疼痛的影响,并表示为百分比变化。通过对每个药物类别的研究特定效果进行加权平均,以获得每个药物类别的总体效果,权重基于每个研究的样本量。
共纳入 29 项研究。共有 43 个治疗臂(乙酰氨基酚 n = 6,口服 NSAIDs n = 9,局部 NSAIDs n = 8,COX-2 抑制剂 n = 9,阿片类药物 n = 11)评估了疼痛的影响。疼痛相对变化(%)如下:乙酰氨基酚= 32.5,口服 NSAIDs = 34.3,局部 NSAIDs = 40.9,COX-2 抑制剂 = 36.9,阿片类药物= 35.4。
使用从 2006 年至 2016 年发表的 29 项研究中提取的数据,对治疗 OA 疼痛的 5 大药物类别进行了回顾。发现乙酰氨基酚的 RC 值接近口服 NSAIDs。口服 NSAIDs、COX-2 抑制剂和阿片类药物在控制疼痛方面的效果与以往文献中的结果相似。局部 NSAIDs 的 RC 值大于口服 NSAIDs。